Want to see TSE:BBM full AI Analyst Report?
BBM Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)5.76K
Market Cap
C$4.95M
Enterprise ValueC$5.08M
Total Cash (Recent Filing)C$102.83K
Total Debt (Recent Filing)C$227.48K
Price to Earnings (P/E)―
Beta-3.18
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume100
30 Day Avg. Volume5,759
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low reported debt-to-equity (~0.02) reduces near-term solvency and refinancing risk, giving management flexibility to prioritize R&D or clinical programs without immediate debt pressure. This structural low leverage cushions the business while it works to stabilize cash flows.
Positive Gross MarginA gross margin near 32% shows the company’s core products or services can generate positive unit economics, implying production and variable costs are manageable. This provides a durable foundation: if operating costs are controlled, gross profit can support a path toward sustained profitability.
Improving Cash Burn TrendAlthough OCF and FCF remain negative, the documented improvement versus 2025 indicates the firm has begun reducing cash consumption. If this trend continues, it lengthens runway, reduces near-term financing pressure, and supports gradual execution on product development and commercialization.
Bears Say
Revenue Decline & VolatilityA very sharp and large decline in TTM revenue signals unstable demand and weak commercial traction. Persistent top-line volatility undermines planning, makes it harder to scale operations profitably, and raises the probability that losses will continue absent a durable recovery in sales.
Persistent Negative Cash FlowOngoing negative operating and free cash flow mean the company is still burning cash to run operations. This structural cash deficit forces reliance on external financing or equity issuance, which can dilute investors and limit the firm’s ability to invest in growth or clinical development long-term.
Eroding Equity & Negative ROERapid decline in shareholders' equity and strongly negative ROE indicate ongoing value destruction from losses. A diminished equity base reduces the company’s capacity to absorb further losses, constrains financial flexibility, and makes raising capital on favorable terms more difficult over the medium term.
Blueberries Medical News
BBM FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is C$4.95M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Sep 02, 2026 which is in 62 days.
How were Blueberries Medical Corp’s earnings last quarter?
Currently, no data Available
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in TSE:BBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.
Technical Analysis
Options Prices
Currently, No data available
---